ETF Building Blocks Content Hub Don’t Miss Out on Rampant Biotech Mergers with the SBIO ETF By Tom LydonJanuary 13, 2021
Featured As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally By Ian YoungDecember 3, 2020
ETF Building Blocks Content Hub How Increased FDA Activity Can Benefit ETFs in Your Portfolio By Tom LydonNovember 19, 2020
Beyond Basic Beta Content Hub Bullish on Biotech? The BBH ETF is Not Just a 2020 Play By Ben HernandezNovember 18, 2020
Equity ETF Content Hub Biotech ETFs Poised for Gains after Moderna Vaccine News By Ian YoungNovember 16, 2020
ETF Building Blocks Content Hub More than Just COVID: Hot ETFs for Medical Breakthroughs By Tom LydonNovember 5, 2020
Beyond Basic Beta Content Hub Can’t Get Enough Biotech Exposure in Your Portfolio? By Ben HernandezOctober 29, 2020
ETF Building Blocks Content Hub Post-Election Considerations for a Nifty Biotech ETF By Tom LydonOctober 7, 2020
